Viewing Study NCT04417192


Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2025-12-26 @ 1:50 PM
Study NCT ID: NCT04417192
Status: COMPLETED
Last Update Posted: 2023-07-06
First Post: 2020-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer
Sponsor: National Cancer Center Hospital East
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module